BD's New Revello Stent Gains CE Marking, Advancing Iliac Artery Treatment across the EU BD has obtained CE marking for its innovative Revello vascular covered stent, a key advancement in treating abdominal artery disease in Europe.

BD's New Revello Stent Gains CE Marking, Advancing Iliac Artery Treatment across the EU #United_States #Franklin_Lakes #Revello_Stent #Nitens_Stent #BD_Technologies

BD's Innovative Revello Stent Advances Iliac Artery Treatments in Europe BD has announced the CE marking of the Revello™ Vascular Covered Stent, enhancing iliac artery treatment options in Europe, addressing critical PAD challenges.

BD's Innovative Revello Stent Advances Iliac Artery Treatments in Europe #USA #Franklin_Lakes #Becton_Dickinson #Revello_Stent #Iliac_Arteries

BD Enhances Iliac Artery Treatment with Innovative Stent in the EU BD has secured CE Mark for its Revello™ Vascular Covered Stent, targeting iliac artery disease. This innovation promises improved treatment for those with peripheral artery disease in Europe.

BD Enhances Iliac Artery Treatment with Innovative Stent in the EU #United_States #Franklin_Lakes #Becton_Dickinson #CE_Mark #Revello_Stent

BD Reaches Key Enrollment Milestone in AGILITY Study for Revello™ Stent in PAD Treatment BD has achieved full enrollment in its AGILITY study for the Revello™ Vascular Covered Stent, critical for treating Peripheral Artery Disease (PAD).

BD Reaches Key Enrollment Milestone in AGILITY Study for Revello™ Stent in PAD Treatment #None #Franklin_Lakes #Becton_Dickinson #Peripheral_Artery_Disease #Revello_Stent